nad has been researched along with naphthalimides in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burkart, V; Bürkle, A; Hartmann, B; Heller, B; Kolb, H; Kröncke, KD; Radons, J; Rodriguez, ML | 1 |
| Hasmann, M; Nüssler, V; Pelka-Fleischer, R; Pogrebniak, A; Schemainda, I | 1 |
| Armstrong, S; Merrill, AR | 1 |
| Kabra, DG; Kaul, CL; Sharma, SS; Thiyagarajan, M | 1 |
| Bhattacharyya, NP; Ghosh, U | 1 |
| Kaundal, RK; Kumar, A; Sharma, SS | 1 |
| Aguilar-Quesada, R; Almendros, A; de Murcia, G; Martín-Oliva, D; Menissier de Murcia, J; Muñoz-Gámez, JA; Oliver, FJ; Quiles-Pérez, R; Rodríguez-Vargas, JM; Ruiz de Almodóvar, M | 1 |
| Arora, M; Kaundal, RK; Kumar, A; Sharma, SS | 1 |
| Haikarainen, T; Lee, HW; Lehtiö, L; Narwal, M; Nkizinkiko, Y; Obaji, E; Venkannagari, H | 1 |
| Areti, A; Gogoi, R; Komirishetty, P; Kumar, A; Sistla, R | 1 |
| Dziadek, J; Hoffmann, M; Korycka-Machala, M; Kuron, A; Nowosielski, M; Olejniczak, A; Rykowski, S | 1 |
| Baud, D; El-Hossary, EM; Förstner, KU; François, P; Holzgrabe, U; Ohlsen, K; Schrenzel, J; Streker, K | 1 |
| Chi, SG; Jung, E; Kim, JS; Lee, MH; Park, SY | 1 |
13 other study(ies) available for nad and naphthalimides
| Article | Year |
|---|---|
Nitric oxide toxicity in islet cells involves poly(ADP-ribose) polymerase activation and concomitant NAD+ depletion.
Topics: 1-Naphthylamine; Animals; Benzamides; Cell Survival; Cells, Cultured; DNA Damage; Enzyme Activation; Islets of Langerhans; Kinetics; NAD; Naphthalimides; Niacinamide; Nitric Oxide; Penicillamine; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Rats; Rats, Wistar; S-Nitroso-N-Acetylpenicillamine; Time Factors | 1994 |
Poly ADP-ribose polymerase (PARP) inhibitors transiently protect leukemia cells from alkylating agent induced cell death by three different effects.
Topics: 1-Naphthylamine; Adenosine Triphosphate; Alkylating Agents; Apoptosis; Benzamides; Cell Death; Cell Line, Tumor; Cell Size; Enzyme Inhibitors; HL-60 Cells; Humans; Leukemia; Melphalan; Methylnitronitrosoguanidine; NAD; Naphthalimides; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones | 2003 |
Toward the elucidation of the catalytic mechanism of the mono-ADP-ribosyltransferase activity of Pseudomonas aeruginosa exotoxin A.
Topics: 1-Naphthylamine; Adenosine Diphosphate; Adenosine Diphosphate Ribose; Adenosine Monophosphate; ADP Ribose Transferases; Bacterial Toxins; Binding, Competitive; Catalysis; Enzyme Activation; Exotoxins; Fluorescence Resonance Energy Transfer; Kinetics; Mutagenesis, Site-Directed; NAD; Naphthalimides; Niacinamide; Peptide Elongation Factor 2; Protein Binding; Pseudomonas aeruginosa; Pseudomonas aeruginosa Exotoxin A; Quinolones; Recombinant Proteins; Substrate Specificity; Virulence Factors | 2004 |
Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Topics: 1-Naphthylamine; Animals; Brain Chemistry; Brain Ischemia; Enzyme Inhibitors; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; NAD; Naphthalimides; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Quinolones; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2004 |
Benzamide and 4-amino 1,8 naphthalimide treatment inhibit telomerase activity by down-regulating the expression of telomerase associated protein and inhibiting the poly(ADP-ribosyl)ation of telomerase reverse transcriptase in cultured cells.
Topics: 1-Naphthylamine; Benzamides; Blotting, Western; Cells, Cultured; DNA-Binding Proteins; Down-Regulation; Enzyme Inhibitors; Humans; Immunoprecipitation; K562 Cells; NAD; Naphthalimides; Poly Adenosine Diphosphate Ribose; Quinolones; Reverse Transcriptase Polymerase Chain Reaction; Telomerase | 2005 |
Protective effects of 4-amino1,8-napthalimide, a poly (ADP-ribose) polymerase inhibitor in experimental diabetic neuropathy.
Topics: 1-Naphthylamine; Animals; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Humans; Male; NAD; Naphthalimides; Neural Conduction; Pain Measurement; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quinolones; Rats; Rats, Sprague-Dawley; Streptozocin | 2008 |
PARP-1 is involved in autophagy induced by DNA damage.
Topics: 1-Naphthylamine; 3T3 Cells; Adenosine Triphosphate; Animals; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 5; Beclin-1; Cell Survival; DNA Damage; Doxorubicin; Enzyme Activation; Gene Deletion; Mice; Microtubule-Associated Proteins; Mitochondria; Models, Biological; NAD; Naphthalimides; Necrosis; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Kinases; Proteins; Quinolones; Subcellular Fractions; TOR Serine-Threonine Kinases; Up-Regulation | 2009 |
Neuroprotective potential of combination of resveratrol and 4-amino 1,8 naphthalimide in experimental diabetic neuropathy: focus on functional, sensorimotor and biochemical changes.
Topics: 1-Naphthylamine; Animals; Antioxidants; Diabetic Neuropathies; Male; Malondialdehyde; NAD; Naphthalimides; Neural Conduction; Neuralgia; Neuroprotective Agents; Oxidative Stress; Pain Measurement; Peroxynitrous Acid; Poly Adenosine Diphosphate Ribose; Quinolones; Rats; Rats, Sprague-Dawley; Resveratrol; Sciatic Nerve; Stilbenes | 2009 |
Structural basis and selectivity of tankyrase inhibition by a Wnt signaling inhibitor WIKI4.
Topics: Amino Acid Sequence; Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Crystallography, X-Ray; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Molecular Sequence Data; NAD; Naphthalimides; Protein Binding; Recombinant Proteins; Sensitivity and Specificity; Tankyrases; Triazoles; Wnt Signaling Pathway | 2013 |
Combination strategy of PARP inhibitor with antioxidant prevent bioenergetic deficits and inflammatory changes in CCI-induced neuropathy.
Topics: 1-Naphthylamine; Adenosine Triphosphate; Animals; Antioxidants; Encephalitis; Hyperalgesia; Male; Mitochondria; NAD; Naphthalimides; Neuralgia; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Quercetin; Quinolones; Rats; Rats, Sprague-Dawley; Sciatic Nerve | 2017 |
Naphthalimides Selectively Inhibit the Activity of Bacterial, Replicative DNA Ligases and Display Bactericidal Effects against Tubercle Bacilli.
Topics: Antitubercular Agents; Bacterial Proteins; DNA Ligases; Enzyme Inhibitors; High-Throughput Screening Assays; Isoquinolines; Molecular Docking Simulation; Mycobacterium tuberculosis; NAD; Naphthalimides | 2017 |
A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase.
Topics: Amines; Anti-Bacterial Agents; Bacterial Proteins; Biotransformation; Color; Culture Media; Drug Resistance, Bacterial; Gene Deletion; Gene Expression; Humans; Inactivation, Metabolic; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; NAD; Naphthalimides; Nitro Compounds; Nitroreductases; Oxidation-Reduction | 2018 |
Cancer-Specific hNQO1-Responsive Biocompatible Naphthalimides Providing a Rapid Fluorescent Turn-On with an Enhanced Enzyme Affinity.
Topics: A549 Cells; Biocompatible Materials; Cell Line, Tumor; Enzyme Assays; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Microscopy, Confocal; NAD; NAD(P)H Dehydrogenase (Quinone); Naphthalimides; Spectrometry, Fluorescence | 2019 |